You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

April 13, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Children's use of antipsychotics may increase risk of diabetes

Initiating antipsychotics may elevate a child's risk not only for significant weight gain, but also for type 2 diabetes by nearly 50%, according to a study in JAMA Pediatrics. Moreover, among children who are also receiving antidepressants, the risk may double. » More on Medicaid-enrolled children

Report: Diabetes drives traditional drug trend, specialty trend increases 20%

Diabetes accounts for a major share of the increase in traditional drug trend, according to a new report. » Catamaran data

Continuing Education

2015 Updates on the national guidelines for diabetes management and related disorders

Last month and this month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. The goal of this month's activity is to discuss the recent updates of national U.S. guidelines for diabetes management, including hypertension and cholesterol management in patients with diabetes, in order to empower pharmacists in clinical decision-making.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT16-TAJ88.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA approves breath test to help diagnose gastroparesis

The Gastric Emptying Breath Test (GEBT) (Advanced Breath Diagnostics) is a non-invasive test used to help diagnose gastroparesis. Current tests used in the diagnosis typically involve the use of a small amount of radioactive material or particular imaging equipment, which restricts their use to specialized outpatient centers. » Read more

 

RELATED ARTICLES

Study finds earlier diabetes diagnoses in Medicaid expansion states

FDA should pull diabetes drug ads, group says

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group